SBRI Healthcare provides funding and support to early-stage projects, enabling testing for business feasibility and technology development, as well as to more mature products by supporting real-world implementation studies. 

The competitions aim to accelerate innovative technologies in the NHS and the wider health and social care system, tackling unmet health and care needs.

Funding is available for phase 1 and 3 of the competition, looking for innovations that can help stroke services, urgent and emergency care, women’s health and Antimicrobial Resistance (AMR).

Competition 25 – AMR and women’s health

Applications close 28 August 2024 1pm. Projects will commence in January 2025. Phase 1 contracts for technical and commercial feasibility testing are valued at up to £100,000 (NET) and will last for six months.

Competition 26 – Urgent & emergency care and stroke 

Applications close 18 September 2024, 1pm. Projects are scheduled to start between January and February 2025. Contracts will last up to 12 months and are valued at up to £500,000 (NET) per project.

Find out more via SBRI’s website. 

Latest Opportunities

Exporting Starts Here programme for West Midlands companies

West Midlands Combined Authority (WMCA), funded by the UK Shared Prosperity Fund (UKSPF), has commissioned…

NIHR i4i Connect funding call

The NIHR Invention for Innovation (i4i) programme is accepting outline applications to their latest researcher-led Connect funding…

Study brief: The effects of a recovery gel on endurance cycling performance in the heat

The popularity of endurance sports like cycling and running has grown significantly over the past…

Latest News

Blog: Why cleanrooms are essential for medical-grade cannabis companies

By Medilink Midlands Member Airology Systems The demand for medical-grade cannabis has surged in recent…

Australia’s Cannim partners with PHTA to advance medicinal cannabis research

Leading medicinal cannabis company Cannim has announced its UK operations will be based at Birmingham’s…

New sleep trial shows dramatic benefits for participants

Cambridge Sleep Sciences (CSS), a leading UK innovator in sleep technology, has announced groundbreaking results…